Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer

Equality impact assessment (guidance development) (PDF 143 KB)

Final draft guidance

Final draft guidance (PDF 132 KB)

Committee papers (PDF 4.08 MB)

Public committee slides (PowerPoint 1020 KB)

Equality impact assessment (downloadable version) (PDF 120 KB)

Final scope (PDF 195 KB)

Final stakeholder list (PDF 165 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 211 KB)

Draft scope post referral (PDF 209 KB)

Draft matrix post referral (PDF 165 KB)